They translated these findings to patients with AD and identified DNA methylation–associated silencing of three target genes: thromboxane A2 receptor (TBXA2R), sorbin and SH3 domain containing 3 (SORBS3) and spectrin β 4 (SPTBN4). Here, SORBS3 is linked to Alzheimer disease.